Risankizumab (anti-IL-23)
Catalogue Number: A2046-SEL
| Manufacturer: | Selleck Chemicals |
| Type: | Recombinant Monoclonal |
| Shipping Condition: | Dry Ice |
| Unit(s): | 1 mg, 5 mg, 25 x 1 mg |
Additional Text
CAS Number
1612838-76-2
Short Description
Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.
Storage Note
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
A2046 MSDS
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations